Full clawback for Trauson in $100m IPO
Retail investors lured by heady growth prospects in the Chinese healthcare sector oversubscribed the HK$750m ($96m) IPO of orthopedic products firm Trauson, which priced on Wednesday morning close to the top of the range.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: